ICH M4Q(R2) 质量指南：人用药品注册通用技术文档 (CTD)：质量

VIP免费

3.0 冒牌货 2025-12-22 117 569.26KB 59 页 80质量币

侵权投诉

INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL

REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE

ICH HARMONISED GUIDELINE

THE COMMON TECHNICAL DOCUMENT FOR

THE REGISTRATION OF PHARMACEUTICALS

FOR HUMAN USE: QUALITY

M4Q(R2)

Draft version

Endorsed on 14 May 2025

Currently under public consultation

At Step 2 of the ICH Process, a consensus draft text or guideline, agreed by the

appropriate ICH Expert Working Group, is transmitted by the ICH Assembly to the

regulatory authorities of the ICH regions for internal and external consultation,

according to national or regional procedures.

M4Q(R2)

Document History

Code

History

Date

M4Q(R2)

Endorsement by the Members of the ICH

Assembly under Step 2 and release for public

consultation.

14 May 2025

Legal notice: This document is protected by copyright and may, with the exception of the ICH

logo, be used, reproduced, incorporated into other works, adapted, modified, translated or

distributed under a public license provided that ICH's copyright in the document is

acknowledged at all times. In case of any adaption, modification or translation of the document,

reasonable steps must be taken to clearly label, demarcate or otherwise identify that changes

were made to or based on the original document. Any impression that the adaption,

modification or translation of the original document is endorsed or sponsored by the ICH must

be avoided.

The document is provided "as is" without warranty of any kind. In no event shall the ICH or the

authors of the original document be liable for any claim, damages or other liability arising from

the use of the document.

The above-mentioned permissions do not apply to content supplied by third parties. Therefore,

for documents where the copyright vests in a third party, permission for reproduction must be

obtained from this copyright holder.

iii

ICH HARMONISED GUIDELINE

THE COMMON TECHNICAL DOCUMENT FOR THE

REGISTRATION OF PHARMACEUTICALS FOR

HUMAN USE: QUALITY

M4Q(R2)

ICH Consensus Guideline

TABLE OF CONTENTS

SCOPE AND ORGANISATION ...................................................................................................... 1

MODULE 2. COMMON TECHNICAL DOCUMENT SUMMARIES ....................................... 4

2.3. Quality Overview ..........................................................................................................................4

2.3.1 General Information....................................................................................................................4

2.3.2 Overall Development and Overall Control Strategy.................................................................. 4

2.3.2.1 Quality Target Product Profile ...................................................................................... 4

2.3.2.2 Overall Development Strategy ...................................................................................... 5

2.3.2.3 Overall Control Strategy Representation ...................................................................... 5

2.3.3 Core Quality Information........................................................................................................... 5

2.3.3.DS Drug Substances.........................................................................................................5

2.3.3.SI Substance Intermediates, if Applicable ........................................................................ 8

2.3.3.SM Starting/Source Materials .......................................................................................... 9

2.3.3.RM Raw Materials ............................................................................................................9

2.3.3.EX Excipients................................................................................................................. 10

2.3.3.RS Reference Standards and/or Materials ......................................................................11

2.3.3.DP Drug Products .......................................................................................................... 12

2.3.3.PI Product Intermediates, if Applicable ......................................................................... 14

2.3.3.MD Medical Devices, if Applicable ................................................................................14

2.3.3.PM Packaged Medicinal Products for multiconstituent products, if Applicable........... 16

2.3.3.PH Pharmaceutical Product after transformation, if Applicable.................................. 17

2.3.3.AP Analytical Procedures ...............................................................................................17

2.3.3.FA Facilities....................................................................................................................18

2.3.4 Development Summary and Justification .................................................................................18

2.3.4.IN Integrated Development and Justifications ...............................................................18

2.3.4.DS Drug Substances.......................................................................................................20

文档加载中……请稍候！
如果长时间未打开，您也可以点击刷新试试。

下载文档到电脑，查找使用更方便

立即下载 VIP免费下载

标签： #注册 #指南 #ICH

摘要：

iINTERNATIONALCOUNCILFORHARMONISATIONOFTECHNICALREQUIREMENTSFORPHARMACEUTICALSFORHUMANUSEICHHARMONISEDGUIDELINETHECOMMONTECHNICALDOCUMENTFORTHEREGISTRATIONOFPHARMACEUTICALSFORHUMANUSE:QUALITYM4Q(R2)DraftversionEndorsedon14May2025CurrentlyunderpublicconsultationAtStep2oftheICHProcess,aconsensusdraftt...

展开>> 收起<<

ICH M4Q(R2) 质量指南：人用药品注册通用技术文档 (CTD)：质量.pdf

共59页,预览50页

还剩页未读，继续阅读

声明：如果您的权利被侵害，请联系我们的进行举报。

ICH M4Q(R2) 质量指南：人用药品注册通用技术文档 (CTD)：质量

相关推荐

相关内容

热门标签

举报选择: